Causality Assessment
Causality assessment is the assessment of relationship between a treatment drug and the occurrence of an adverse event. Causality assessment of ADRs is a method used for estimating the strength of relationship between drug(s) exposure and occurrence of adverse reaction(s). Causality terms include certain, probable/likely, possible, unlikely, conditional, and unassessable. Naranjo algorithm,[6] was developed in 1991 by Naranjo et al., from the University of Toronto and is often referred to as the Naranjo Scale.
Related Conference of Causality Assessment
November 20-21, 2024
15th International Conference onPharmacoepidemiology and Clinical Research
Vancouver, Canada
November 25-26, 2024
10th International Conference on Antimicrobials & Antibiotic Resistance
Vancouver, Canada
November 26-27, 2024
3rd World Conference on Pharma Industry and Medical Devices
Zurich, Switzerland
November 28-29, 2024
41st International Conference on Drug Discovery and Drug delivery system
Paris, France
November 28-29, 2024
16th International Conference on Biosimilars and Pharma Innovations
Bali, Indonesia
December 12-13, 2024
12th International Conference and Exhibition on Natural Products and Medicinal Plants Research
Rome, Italy
March 13-14, 2025
8th International on Pharmacy and Pharmaceutical Conference
Prague, Czech Republic
April 07-08, 2025
4th International Conference and Expo on Pharmaceutics & Novel Drug Delivery Systems
Vancouver, Canada
May 05-06, 2025
17th International Conference on Pharmaceutical Education and Practice
Vancouver, Canada
June 02-03, 2025
31st International Conference on Advanced Clinical Research and Clinical Trials
Amsterdam, Netherlands
June 10-11, 2025
24th International Conference on Medicinal and Pharmaceutical Chemistry
Vancouver, Canada
June 10-11, 2025
7th International Conference and Exhibition on Pharmaceutical Development and Technology
Vancouver, Canada
June 16-17, 2025
18th International Conference and Exhibition on Pharmacovigilance & Drug Safety
Frankfurt, Germany
June 23-24, 2025
25th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry
Paris, France
September 23-24, 2025
10th International Conference on Future Pharma and Innovations
Amsterdam, Netherlands
October 22-23, 2025
7th European Conference on Advance Clinical Trials and Research
Aix-en-Provence, France
Causality Assessment Conference Speakers
Recommended Sessions
- Adverse Drug Reactions
- Analysis of Data Quality and Management
- Biopharmaceutics
- Causality Assessment
- Clinical Database Management
- Clinical Trial Protocols
- Clinical Trials Pharmacovigilance
- Global Clinical Trials
- Orphan drugs
- Pharmaceutical Chemistry
- Pharmaceutical Nanotechnology
- Pharmacokinetics
- Pharmacovigilance and Clinical Trials
- Pharmacovigilance Practice
- Regulatory Affairs
Related Journals
Are you interested in
- 3D Printing of Drugs - PHARMA CONFERENCE-2025 (Czech Republic)
- Action of drugs - Pharmacoepidemiology Congress 2024 (Canada)
- Active Pharmaceutical Ingredients - MedTech-2024 (Switzerland)
- Acupuncture - Natural Products 2024 (Italy)
- Adaptive Trial Models in Research - Clinical Trials Congress-2025 (France)
- Advanced Analytical Techniques in Drug Development - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Advanced Drug Delivery System - BIOSIMILARS-2024 (Indonesia)
- Advanced Drug Delivery Systems - PHARMA CONFERENCE-2025 (Czech Republic)
- Advanced Methodologies in Pharmacoepidemiology - Pharmacoepidemiology Congress 2024 (Canada)
- Advancements in drug delivery systems - Pharmaceutica-2025 (Canada)
- Advancements in Drug Discovery - Pharmacology-2024 (France)
- Advancements in Pharmacovigilance - Clinical Trials Congress-2025 (France)
- Advances in Cardiovascular Drug Discovery - Cardiovascular-2025 (France)
- Advances in Controlled Release Formulations - Pharmaceutica-2025 (Canada)
- Advances in Drug Discovery - Clinical Trials Congress-2025 (France)
- Advances in Pharmaceutical Packaging - PHARMACEUTICAL SCIENCES 2025 (France)
- Advances in Vaccine Delivery - Drug Delivery-2024 (France)
- Alternative Medicine and Complementary Medicine - Natural Products 2024 (Italy)
- Analysis and Quality Control for Pharmaceuticals - Drug Safety 2024 (France)
- Analytical Biotechnology - Biotech-2025 (France)
- Analytical Chemistry - PHARMAKON 2025 (Spain)
- Analytical strategies for pharmaceutical products - MedTech-2024 (Switzerland)
- Antibiotic Prophylaxis - Antibiotics Resistance 2024 (Canada)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics Resistance 2024 (Canada)
- Antibiotic-resistant Bacterial infections - Antibiotics Resistance 2024 (Canada)
- Antibiotics - Antibiotics Resistance 2024 (Canada)
- Antibiotics - PHARMAKON 2025 (Spain)
- Antibiotics for Various Diseases and Infections - Antibiotics Resistance 2024 (Canada)
- Antimicrobial Peptides - Antibiotics Resistance 2024 (Canada)
- Antimicrobial Therapy - Antibiotics Resistance 2024 (Canada)
- Application of Pharmacology in Medical Science - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Applied Medicinal Chemistry - PHARMAKON 2025 (Spain)
- Applied Microbiology - Biotech-2025 (France)
- Artificial Intelligence (AI) - Personalizedmedicine-2024 (Switzerland)
- Artificial Intelligence and Machine Learning in Drug Delivery Optimization - Pharmaceutica-2025 (Canada)
- Artificial Intelligence and Machine Learning in Pharmaceutical Chemistry - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Artificial Intelligence in Drug Discovery - PHARMA CONFERENCE-2025 (Czech Republic)
- BCS and IVIVC Based Biowaivers - BIOSIMILARS-2024 (Indonesia)
- BCS and IVIVC Based Biowaivers - BIOSIMILARS-2024 (Indonesia)
- BCS and IVIVC Based Biowaivers - Eurobiosimilars 2025 (France)
- Big data analytics and Pharma - Future Pharma 2025 (Netherlands)
- Bio Molecular Dynamics - Biotech-2025 (France)
- Bio-Organic Chemistry - PHARMAKON 2025 (Spain)
- Bioequivalence and Bioavailability - MedTech-2024 (Switzerland)
- Bioethics and Regulatory Compliance - Clinical-Trials-2024 (Canada)
- Bioinformatics - Pharma Europe 2025 (Italy)
- Bioisosteres - PHARMAKON 2025 (Spain)
- Biological Drugs in Autoimmune Diseases - PHARMAKON 2025 (Spain)
- Biological Medicine - BIOSIMILARS-2024 (Indonesia)
- Biological Medicine - Eurobiosimilars 2025 (France)
- Biologics and Biosimilars - Pharmaceutica-2025 (Canada)
- Biologics and Biosimilars - PHARMA CONFERENCE-2025 (Czech Republic)
- Biomarker Discovery in Drug Development - Clinical Trials Congress-2025 (France)
- Biomarkers - Personalizedmedicine-2024 (Switzerland)
- Biomarkers and Precision Medicine - Pharmacoepidemiology Congress 2024 (Canada)
- Biomarkers in Cardiovascular Disease and Drug Response - Cardiovascular-2025 (France)
- Biomaterials and Biodegradable Polymers in Drug Delivery - Drug Delivery-2024 (France)
- Biopharmaceutical Formulation Development - Drug Delivery-2024 (France)
- Biopharmaceutical Informatics - BIOSIMILARS-2024 (Indonesia)
- Biopharmaceutical Informatics - Eurobiosimilars 2025 (France)
- Biopharmaceuticals - Biotech-2025 (France)
- Biopharmaceuticals and Biotechnology - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Biopharmaceuticals, Biomolecules, and Therapeutics - Drug Safety 2024 (France)
- Biopharmaceutics and Drug Disposition - Pharmaceutica-2025 (Canada)
- Biosimilars - BIOSIMILARS-2024 (Indonesia)
- Biosimilars - Biotech-2025 (France)
- Biosimilars Approval to Biogenerics in Clinical Practice - Eurobiosimilars 2025 (France)
- Biosimilars Development in Markets - Eurobiosimilars 2025 (France)
- Biosimilars Market and Cost Analysis - Eurobiosimilars 2025 (France)
- Biosimilars Research Pipeline - Eurobiosimilars 2025 (France)
- Biotechnology and Biopharmaceuticals - PHARMA CONFERENCE-2025 (Czech Republic)
- Biotechnology and Microbiology in Pharmaceuticals - Drug Safety 2024 (France)
- Biotechnology in Pharmacotherapy - Pharmacology-2024 (France)
- Cancer Biotechnology - Biotech-2025 (France)
- Cancer Clinical Research Progress - Clinical Trials Congress-2025 (France)
- Cardiac Arrhythmias and Pharmacotherapy - Cardiovascular-2025 (France)
- Cardio protective Agents: Mechanisms and Applications - Cardiovascular-2025 (France)
- Cardiovascular Drug Safety and Toxicology - Cardiovascular-2025 (France)
- Cardiovascular Pharmacology in Special Populations - Cardiovascular-2025 (France)
- Cellular Targeting and subcellular Delivery - Drug Safety 2024 (France)
- Challenges and Future Innovations of Traditional Medicine - Natural Products 2024 (Italy)
- Challenges in Biosimilars Pharmacovigilance - Eurobiosimilars 2025 (France)
- Challenges in Drug Formulation and Stability - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Challenges In Pharmaceutical Formulations - Pharmatech 2025 (Canada)
- Chemical and Analytical Strategies for Biosimilars - BIOSIMILARS-2024 (Indonesia)
- Chemical and Analytical Strategies for Biosimilars - Eurobiosimilars 2025 (France)
- Chemical Synthesis and Catalysis - PHARMAKON 2025 (Spain)
- Chemo genomics - PHARMAKON 2025 (Spain)
- Chromatography & Separation Techniques - PHARMAKON 2025 (Spain)
- Chronic Disease Management and Palliative Care - NURSING PHARMACOLOGY 2024 (Netherlands)
- Clinical and Hospital Pharmacy - PHARMACEUTICAL SCIENCES 2025 (France)
- Clinical and Hospital Pharmacy - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Clinical and Hospital Pharmacy - PHARMA CONFERENCE-2025 (Czech Republic)
- Clinical and Hospital Pharmacy - Future Pharma 2025 (Netherlands)
- Clinical and Medical Case Reports - Pharma Europe 2025 (Italy)
- Clinical Data & Analytics Strategies - Clinical Trials Congress-2025 (France)
- Clinical Data Management - Pharmacoepidemiology Congress 2024 (Canada)
- Clinical Data Management and Analytics - Clinical-Trials-2024 (Canada)
- Clinical Operations & Project Management - Clinical-Trials-2024 (Canada)
- Clinical Pharmacology & Receptor Therapy - Clinical Trials Congress-2025 (France)
- Clinical Pharmacy - Pharmacoepidemiology Congress 2024 (Canada)
- Clinical Pharmacy - Pharma Europe 2025 (Italy)
- Clinical Pharmacy and Pharmacy Practices - MedTech-2024 (Switzerland)
- Clinical Pharmacy and Therapeutics - PHARMACEUTICAL SCIENCES 2025 (France)
- Clinical research - Pharmacoepidemiology Congress 2024 (Canada)
- Clinical Research & Clinical Trials - PHARMA CONFERENCE-2025 (Czech Republic)
- Clinical Research & Clinical Trials: Academic Perspective - Clinical-Trials-2024 (Canada)
- Clinical Research and Drug Development - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Clinical Supply Management - Clinical-Trials-2024 (Canada)
- Clinical Trial Auditing Innovations - Clinical Trials Congress-2025 (France)
- Clinical Trial Efficiency Factors - Clinical Trials Congress-2025 (France)
- Clinical Trial Forecasting, Budgeting and Contracting - Clinical-Trials-2024 (Canada)
- Clinical Trial Site Selection and Management - Clinical-Trials-2024 (Canada)
- Clinical Trials - Personalizedmedicine-2024 (Switzerland)
- Clinical trials - Pharmacoepidemiology Congress 2024 (Canada)
- Clinical Trials - Clinical Trials Congress-2025 (France)
- Clinical Trials & Safety Monitoring - Clinical Trials Congress-2025 (France)
- Clinical trials and Pharmacovigilance - MedTech-2024 (Switzerland)
- Clinical Trials of Antibiotics - Antibiotics Resistance 2024 (Canada)
- Clinical Trials on different Diseases - Clinical-Trials-2024 (Canada)
- Computational Chemistry and Molecular Modeling - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Computer Assisted Drug Design - Biotech-2025 (France)
- Computer-Aided Drug Design - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Consequences of Brexit on Biosimilars - BIOSIMILARS-2024 (Indonesia)
- Consequences of Brexit on Biosimilars - Eurobiosimilars 2025 (France)
- COVID-19 and Drug Repurposing - PHARMA CONFERENCE-2025 (Czech Republic)
- CRO, Sponsorship & Outsourcing for Clinical Trials - Clinical-Trials-2024 (Canada)
- Crude Drugs and Plant Products - Natural Products 2024 (Italy)
- Current Agency Expectations for Approval for Biosimilars - Eurobiosimilars 2025 (France)
- Current Challenges in Developing Biosimilars - Eurobiosimilars 2025 (France)
- Current research in antibiotic resistance - Antibiotics Resistance 2024 (Canada)
- Cutting-edge Imaging Research - Clinical Trials Congress-2025 (France)
- Data Analytics - Personalizedmedicine-2024 (Switzerland)
- Decentralized and Virtual Clinical Trials - Pharmacoepidemiology Congress 2024 (Canada)
- Decentralized Trial Models - Clinical Trials Congress-2025 (France)
- Delivery of Medicine via Inhalation - Drug Safety 2024 (France)
- Developing Alternatives to Antibiotics - Antibiotics Resistance 2024 (Canada)
- Development and Production of Pharmaceutical Products - Drug Safety 2024 (France)
- Diagnostics & Medical Devices - Biotech-2025 (France)
- Digital Health - Personalizedmedicine-2024 (Switzerland)
- Digital Health and Pharmacology - Pharmacology-2024 (France)
- Digital Health and Telemedicine - PHARMA CONFERENCE-2025 (Czech Republic)
- Digital Marketing in Pharma Industry - Future Pharma 2025 (Netherlands)
- Digital Pharma - BIOSIMILARS-2024 (Indonesia)
- Digital Pharma - PHARMACEUTICAL SCIENCES 2025 (France)
- Digital Pharma - Pharmatech 2025 (Canada)
- Disease Prevention - Personalizedmedicine-2024 (Switzerland)
- Drug Delivery & Blood-Brain Barrier - Clinical Trials Congress-2025 (France)
- Drug Delivery and Development - Eurobiosimilars 2025 (France)
- Drug Delivery and Gene Therapy - Pharmaceutica-2025 (Canada)
- Drug Delivery Challenges in Neurological Disorders - Drug Delivery-2024 (France)
- Drug Delivery for Cardiovascular Diseases - Pharmaceutica-2025 (Canada)
- Drug Delivery in Cancer Therapy - Pharmaceutica-2025 (Canada)
- Drug Delivery in Infectious Diseases - Pharmaceutica-2025 (Canada)
- Drug Delivery Strategies for Cancer Therapy - Drug Delivery-2024 (France)
- Drug Delivery Systems - Pharma Europe 2025 (Italy)
- Drug Delivery Techniques - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Drug Delivery Technology - BIOSIMILARS-2024 (Indonesia)
- Drug Delivery Technology and Vaccine Design - Drug Safety 2024 (France)
- Drug Delivery Using Peptides and Proteins - Drug Safety 2024 (France)
- Drug Design, Discovery and Development - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Drug Development - PHARMACEUTICAL SCIENCES 2025 (France)
- Drug Development - PHARMAKON 2025 (Spain)
- Drug Discovery - PHARMACEUTICAL SCIENCES 2025 (France)
- Drug Discovery and Development - Clinical-Trials-2024 (Canada)
- Drug Discovery and Development - Future Pharma 2025 (Netherlands)
- Drug Discovery and Development - Pharmatech 2025 (Canada)
- Drug Discovery and Drug Development - Pharmacoepidemiology Congress 2024 (Canada)
- Drug discovery and NCEs - MedTech-2024 (Switzerland)
- Drug Discovery and Novel Delivery Technologies - Antibiotics Resistance 2024 (Canada)
- Drug Formulation - BIOSIMILARS-2024 (Indonesia)
- Drug Formulation - PHARMACEUTICAL SCIENCES 2025 (France)
- Drug Metabolism - PHARMAKON 2025 (Spain)
- Drug Product Manufacturing - Pharmatech 2025 (Canada)
- Drug Regulations - Pharma Europe 2025 (Italy)
- Drug Repurposing and Drug Rediscovery - Pharmacology-2024 (France)
- Drug Repurposing and Drug Rediscovery - Drug Delivery-2024 (France)
- Drug Repurposing in Cardiovascular Medicine - Cardiovascular-2025 (France)
- Drug Research and Evaluation - Drug Safety 2024 (France)
- Drug Safety - Drug Safety 2024 (France)
- Drug Targeting and Design - Pharmaceutica-2025 (Canada)
- Drug Targeting and Design - Pharmatech 2025 (Canada)
- Electronic Health Records (EHRs) - Personalizedmedicine-2024 (Switzerland)
- Emerging Antithrombotic Therapies - Cardiovascular-2025 (France)
- Emerging Biosimilars in Therapeutics - Eurobiosimilars 2025 (France)
- Emerging Technologies in Drug Discovery - Drug Delivery-2024 (France)
- Encapsulated Drugs - BIOSIMILARS-2024 (Indonesia)
- Endothelial Nitric Oxide and Cardiovascular Health - Cardiovascular-2025 (France)
- Enrollment Planning and Patient Recruitment - Clinical-Trials-2024 (Canada)
- Entrepreneurs Investment Meet - PHARMACEUTICAL SCIENCES 2025 (France)
- Environmental Catalysis and Green Chemistry - PHARMAKON 2025 (Spain)
- Epigenetic Therapies in Cancer - PHARMA CONFERENCE-2025 (Czech Republic)
- Ethno pharmacy - PHARMAKON 2025 (Spain)
- Formulation Strategies for Follow-on Biologics - Eurobiosimilars 2025 (France)
- Formulations and NNDS - MedTech-2024 (Switzerland)
- Future of Clinical Trials and Technology Innovations - Clinical-Trials-2024 (Canada)
- Future Perspectives in Drug Discovery and Delivery - Drug Delivery-2024 (France)
- Gene Therapy and RNA-based Therapeutics - Drug Delivery-2024 (France)
- Generics versus Big Pharma - PHARMACEUTICAL SCIENCES 2025 (France)
- Genetic epidemiology - Pharmacoepidemiology Congress 2024 (Canada)
- Genetic Testing - Personalizedmedicine-2024 (Switzerland)
- Genomics - Personalizedmedicine-2024 (Switzerland)
- Genotoxicity - PHARMAKON 2025 (Spain)
- Geriatric Nursing and Age-Related Care - NURSING PHARMACOLOGY 2024 (Netherlands)
- Global Health and Pharmacoepidemiology - Pharmacoepidemiology Congress 2024 (Canada)
- Global Health Challenges and Healthcare Equity - NURSING PHARMACOLOGY 2024 (Netherlands)
- Globalization of Biosimilars - Eurobiosimilars 2025 (France)
- Globalization of Clinical Trials - Clinical-Trials-2024 (Canada)
- Globalized Pharma Sector - PHARMACEUTICAL SCIENCES 2025 (France)
- Green and Community Pharmacy - Future Pharma 2025 (Netherlands)
- Green Chemistry in Pharmaceutical Development - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Health Equity - Personalizedmedicine-2024 (Switzerland)
- Healthcare Policy and Management - NURSING PHARMACOLOGY 2024 (Netherlands)
- Herbal Medicine - Natural Products 2024 (Italy)
- Hereditary Angioedema Research - Clinical Trials Congress-2025 (France)
- Homeopathic and Ayurvedic Medicines - Natural Products 2024 (Italy)
- Hydrogel-Based Delivery for Diabetes - PHARMA CONFERENCE-2025 (Czech Republic)
- Immunology & Vaccines - Antibiotics Resistance 2024 (Canada)
- Immunopharmacology of Autoimmune Disorders - Pharmacology-2024 (France)
- Industrial and Physical Pharmacy - PHARMACEUTICAL SCIENCES 2025 (France)
- Industrial Bioproceses for Drug Production and Development - Biotech-2025 (France)
- Industrial Pharmacy - Pharma Europe 2025 (Italy)
- Industrial Pharmacy and Physical pharmacy - Future Pharma 2025 (Netherlands)
- Infectious Diseases - Antibiotics Resistance 2024 (Canada)
- Innovations in clinical study designs - Clinical-Trials-2024 (Canada)
- Innovations in Clinical Trial Design - Pharmacoepidemiology Congress 2024 (Canada)
- Innovations in Heart Failure Pharmacotherapy - Cardiovascular-2025 (France)
- Innovations in Nursing Technology and Informatics - NURSING PHARMACOLOGY 2024 (Netherlands)
- Innovations in Oral Drug Delivery Systems - Drug Delivery-2024 (France)
- Innovations In Pharmaceutical Technology - Pharmatech 2025 (Canada)
- Innovative Clinical Approach in Biosimilars - Eurobiosimilars 2025 (France)
- Innovative Drug Design and Discovery - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Integrative Medicine and Holistic Healthcare - NURSING PHARMACOLOGY 2024 (Netherlands)
- Intellectual Property Rights - BIOSIMILARS-2024 (Indonesia)
- Intellectual Property Rights - Eurobiosimilars 2025 (France)
- Intellectual property rights and regulatory issues - Drug Safety 2024 (France)
- Legal Issues and BPCI Act - Eurobiosimilars 2025 (France)
- Lifestyle Medicine - Personalizedmedicine-2024 (Switzerland)
- Lipids and Cholesterol Management in Cardiovascular Disease - Cardiovascular-2025 (France)
- Marine Natural Products - Natural Products 2024 (Italy)
- Mass Spectrometry - PHARMAKON 2025 (Spain)
- Mechanism and Evolution of Antibiotic Resistance - Antibiotics Resistance 2024 (Canada)
- Medical and Clinical Case Reports - Clinical-Trials-2024 (Canada)
- Medical Imaging in Clinical Research - Clinical-Trials-2024 (Canada)
- Medicinal Chemistry - Natural Products 2024 (Italy)
- Medicinal Chemistry - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Medicinal Chemistry and Targeted Therapies - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Medicinal Chemistry: Physical Properties and Drug Design - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Medicinal Plant Research - Natural Products 2024 (Italy)
- Medicinal Plants as Anti-Cancer Drugs - Natural Products 2024 (Italy)
- Medico Marketing - PHARMACEUTICAL SCIENCES 2025 (France)
- Mental Health and Psychiatric Nursing - NURSING PHARMACOLOGY 2024 (Netherlands)
- Micro Organisms in Recent Drug Discovery - Antibiotics Resistance 2024 (Canada)
- Microbial & Environmental Biotechnology - Biotech-2025 (France)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics Resistance 2024 (Canada)
- Modern drug delivery techniques - Drug Safety 2024 (France)
- Molecualr Biotechnology - Biotech-2025 (France)
- Molecular and Cellular Pharmacology - PHARMAKON 2025 (Spain)
- Molecular Mechanisms of Cardiovascular Pharmacology - Cardiovascular-2025 (France)
- Monoclonal Antibody Biosimilars - Eurobiosimilars 2025 (France)
- Nano medicine and Nanotechnology in Drug Delivery - Pharmaceutica-2025 (Canada)
- Nanomedicine and Nano Technology - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Nanomedicine in Cardiovascular Pharmacology - Cardiovascular-2025 (France)
- Nanotechnology Applications in Drug Delivery - Drug Delivery-2024 (France)
- Nanotechnology in Drug Delivery - Pharma Europe 2025 (Italy)
- Nanotechnology in Drug Delivery Systems - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Nanotechnology in Drug Discovery - Clinical Trials Congress-2025 (France)
- Natural Products - Natural Products 2024 (Italy)
- Natural Products and Traditional Medicine - PHARMA CONFERENCE-2025 (Czech Republic)
- Natural Products Chemistry - Natural Products 2024 (Italy)
- Natural Products Chemistry - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- New Advances in Drug Delivery Systems - Drug Safety 2024 (France)
- New antibiotics and non-antibiotic approaches - Antibiotics Resistance 2024 (Canada)
- New Sources and Approaches to Natural Products - Natural Products 2024 (Italy)
- Next-Gen Drug Design Techniques - Clinical Trials Congress-2025 (France)
- NMR in Rational Drug Design - PHARMAKON 2025 (Spain)
- Novel Drug Delivery Systems - Future Pharma 2025 (Netherlands)
- Novel Drug Delivery Systems, Biomarkers & Drug Targets - MedTech-2024 (Switzerland)
- Novel Drug Delivery Technologies - Drug Delivery-2024 (France)
- Novel Drug Delivery Technologies - Pharmaceutica-2025 (Canada)
- Novel Target Drugs to the Treatment of Cancer - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Novel Targets in Hypertension Therapy - Cardiovascular-2025 (France)
- Nursing Education and Practice - NURSING PHARMACOLOGY 2024 (Netherlands)
- Nursing Leadership and Professional Development - NURSING PHARMACOLOGY 2024 (Netherlands)
- Nursing Research and Evidence-Based Practice - NURSING PHARMACOLOGY 2024 (Netherlands)
- Nutraceuticals and Functional Medicine - Natural Products 2024 (Italy)
- Organic Chemistry and Inorganic Chemistry - PHARMAKON 2025 (Spain)
- Organic Chemistry in Pharmaceuticals - Clinical Trials Congress-2025 (France)
- Patient Safety and Quality Improvement - NURSING PHARMACOLOGY 2024 (Netherlands)
- Patient-Cantered Care - Personalizedmedicine-2024 (Switzerland)
- Patient-Centered Approaches in Clinical Research - Pharmacoepidemiology Congress 2024 (Canada)
- Patient-Centric Clinical Trials - Clinical-Trials-2024 (Canada)
- Peptide and Protein Drug Delivery - Pharmaceutica-2025 (Canada)
- Personalized Healthcare - Personalizedmedicine-2024 (Switzerland)
- Personalized Medicine in Cardiovascular Care - Cardiovascular-2025 (France)
- Pharma and Biotech Financial Outlook - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharma and Biotech Financial Outlook - Future Pharma 2025 (Netherlands)
- Pharma Companies - Pharma Europe 2025 (Italy)
- Pharma Market Research - MedTech-2024 (Switzerland)
- Pharmaceutical Analysis - Future Pharma 2025 (Netherlands)
- Pharmaceutical Analysis - Pharmatech 2025 (Canada)
- Pharmaceutical Analysis: Analytical Methods - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmaceutical and healthcare Industry - Future Pharma 2025 (Netherlands)
- Pharmaceutical Biotechnology - Pharma Europe 2025 (Italy)
- Pharmaceutical Chemistry - BIOSIMILARS-2024 (Indonesia)
- Pharmaceutical Chemistry - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmaceutical Chemistry - Pharma Europe 2025 (Italy)
- Pharmaceutical Chemistry - Future Pharma 2025 (Netherlands)
- Pharmaceutical Chemistry - Pharmatech 2025 (Canada)
- Pharmaceutical Engineering - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Engineering - Pharma Europe 2025 (Italy)
- Pharmaceutical Formulation Advances - Clinical Trials Congress-2025 (France)
- Pharmaceutical Formulations - Pharma Europe 2025 (Italy)
- Pharmaceutical Industry - Pharmatech 2025 (Canada)
- Pharmaceutical Industry and Market Trends - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Pharmaceutical Manufacturing - BIOSIMILARS-2024 (Indonesia)
- Pharmaceutical Manufacturing and Pharmacoeconomics - MedTech-2024 (Switzerland)
- Pharmaceutical Manufacturing, Scale Up and Tech transfer - MedTech-2024 (Switzerland)
- Pharmaceutical Marketing - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmaceutical Microbiology - Pharma Europe 2025 (Italy)
- Pharmaceutical Microbiology and Biotechnology - PHARMA CONFERENCE-2025 (Czech Republic)
- Pharmaceutical Nanotechnology - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Nanotechnology - Pharma Europe 2025 (Italy)
- Pharmaceutical Packaging and Logistics - MedTech-2024 (Switzerland)
- Pharmaceutical Process Validation - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Research and Development - Pharmatech 2025 (Canada)
- Pharmaceutical Science - Pharmatech 2025 (Canada)
- Pharmaceutical Sciences - Clinical-Trials-2024 (Canada)
- Pharmaceutical Sciences - MedTech-2024 (Switzerland)
- Pharmaceutical sciences - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Sciences - Pharma Europe 2025 (Italy)
- Pharmaceutical Supply Chain Optimization - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Technology - Clinical Trials Congress-2025 (France)
- Pharmaceuticals and Cosmetics - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmaceuticals and Drug Delivery Systems Using Nanotechnology - Drug Safety 2024 (France)
- Pharmaceuticals and Nutraceuticals - PHARMAKON 2025 (Spain)
- Pharmaceutics - Pharma Europe 2025 (Italy)
- Pharmaceutics & Pharmacotherapeutics - Future Pharma 2025 (Netherlands)
- Pharmaceutics and Pharmacotherapeutics - Pharmatech 2025 (Canada)
- Pharmacists Role in Patient Safety - Pharmatech 2025 (Canada)
- Pharmacodynamics - PHARMAKON 2025 (Spain)
- Pharmacoeconomics - MedTech-2024 (Switzerland)
- Pharmacoepidemology and clinical research - Pharmacoepidemiology Congress 2024 (Canada)
- Pharmacoepidemology and public health - Pharmacoepidemiology Congress 2024 (Canada)
- Pharmacogenetics - Personalizedmedicine-2024 (Switzerland)
- Pharmacogenetics & Pharmacogenomics - PHARMA CONFERENCE-2025 (Czech Republic)
- Pharmacogenetics and Personalized Medicine - Pharmacology-2024 (France)
- Pharmacogenomics - Drug Safety 2024 (France)
- Pharmacogenomics - Personalizedmedicine-2024 (Switzerland)
- Pharmacogenomics - BIOSIMILARS-2024 (Indonesia)
- Pharmacogenomics - PHARMAKON 2025 (Spain)
- Pharmacogenomics and Pharmacoepidemiology - MedTech-2024 (Switzerland)
- Pharmacogenomics in Cardiovascular Medicine - Cardiovascular-2025 (France)
- Pharmacognosy - Pharma Europe 2025 (Italy)
- Pharmacognosy - PHARMAKON 2025 (Spain)
- Pharmacokinetics - PHARMAKON 2025 (Spain)
- Pharmacokinetics and Pharmacodynamics - Pharmacology-2024 (France)
- Pharmacokinetics and Pharmacodynamics - Pharmaceutica-2025 (Canada)
- Pharmacokinetics and Pharmacodynamics - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmacokinetics and Pharmacodynamics - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Pharmacokinetics and Pharmacodynamics in Cardiology - Cardiovascular-2025 (France)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics Resistance 2024 (Canada)
- Pharmacological Advances and Drug Development - NURSING PHARMACOLOGY 2024 (Netherlands)
- Pharmacological Approaches to Myocardial Ischemia - Cardiovascular-2025 (France)
- Pharmacological Management of Cardiovascular Risk Factors - Cardiovascular-2025 (France)
- Pharmacological Sciences - Pharma Europe 2025 (Italy)
- Pharmacology - Drug Safety 2024 (France)
- Pharmacology - Pharmacoepidemiology Congress 2024 (Canada)
- Pharmacology - Pharmatech 2025 (Canada)
- Pharmacology & Toxicology - Antibiotics Resistance 2024 (Canada)
- Pharmacology and Toxicology - MedTech-2024 (Switzerland)
- Pharmacology and Toxicology - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmacology of Addiction and Substance Abuse - Pharmacology-2024 (France)
- Pharmacology of Aging and Geriatric Medicine - Pharmacology-2024 (France)
- Pharmacology of Antimicrobial Resistance - Pharmacology-2024 (France)
- Pharmacology of Cancer Immunotherapy - Pharmacology-2024 (France)
- Pharmacology of Cardiovascular Therapeutics - Pharmacology-2024 (France)
- Pharmacology of Neurodegenerative Disorders - Pharmacology-2024 (France)
- Pharmacology of Nutraceuticals and Dietary Supplements - Pharmacology-2024 (France)
- Pharmacology of Pain Management and Analgesia - Pharmacology-2024 (France)
- Pharmacology of Rare Diseases - Pharmacology-2024 (France)
- Pharmacology of Respiratory Diseases: - Pharmacology-2024 (France)
- pharmacotheraphy and drug safety - Pharmacoepidemiology Congress 2024 (Canada)
- Pharmacovigilance and Drug Safety - Clinical-Trials-2024 (Canada)
- Pharmacovigilance and Drug Safety - PHARMA CONFERENCE-2025 (Czech Republic)
- Pharmacovigilance and its Significance - Pharmacoepidemiology Congress 2024 (Canada)
- Pharmacovigilance in the Era of Big Data - Pharmacology-2024 (France)
- Pharmacy Development Services - Pharma Europe 2025 (Italy)
- Pharmacy Education and Practice - PHARMACEUTICAL SCIENCES 2025 (France)
- Photochemistry and Phytopharmaceuticals - PHARMAKON 2025 (Spain)
- Phytochemistry - Natural Products 2024 (Italy)
- Population Health - Personalizedmedicine-2024 (Switzerland)
- Post-Marketing Surveillance Insights - Clinical Trials Congress-2025 (France)
- Post-Trial Closed Communities - Clinical Trials Congress-2025 (France)
- Precision Medicine - Personalizedmedicine-2024 (Switzerland)
- Precision Medicine and Pharmacogenomics - NURSING PHARMACOLOGY 2024 (Netherlands)
- Public Health and Community Nursing - NURSING PHARMACOLOGY 2024 (Netherlands)
- Purpose and Principles of GMP - PHARMACEUTICAL SCIENCES 2025 (France)
- QC & QA: Quality control and Quality assurance - MedTech-2024 (Switzerland)
- Quality by design(QbD) approach - MedTech-2024 (Switzerland)
- Quality Control and Regulatory Considerations in Drug Delivery Systems - Pharmaceutica-2025 (Canada)
- R&D Advancement: Road to New Medicines - PHARMACEUTICAL SCIENCES 2025 (France)
- Radiation-based medicines and biotherapy - Drug Safety 2024 (France)
- Rational Design of Non-Oral Drugs - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Rational Drug Design and Molecular Modeling - PHARMA CONFERENCE-2025 (Czech Republic)
- Real-World Evidence in Clinical Trials - Pharma Europe 2025 (Italy)
- Recent Advancements in Medicinal Pharma - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Reformulation Research - Drug Safety 2024 (France)
- Regenerative Medicine and Tissue Engineering - Drug Delivery-2024 (France)
- Regulatory affairs - Pharmacoepidemiology Congress 2024 (Canada)
- Regulatory Affairs and Drug Safety - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Regulatory Affairs and Intellectual Property Rights - Future Pharma 2025 (Netherlands)
- Regulatory Affairs and Quality Assurance in Pharmaceutics - Pharmaceutica-2025 (Canada)
- Regulatory Authority Compliance - MedTech-2024 (Switzerland)
- Regulatory Considerations in Drug Development - Drug Delivery-2024 (France)
- Regulatory Requirements for Pharmaceuticals - PHARMACEUTICAL SCIENCES 2025 (France)
- Regulatory Updates on Biosimilars - Eurobiosimilars 2025 (France)
- Research and development in pharmaceuticals - Drug Safety 2024 (France)
- Research and Trials on Oncology and AIDS - Clinical-Trials-2024 (Canada)
- Risk Management - Pharmacoepidemiology Congress 2024 (Canada)
- Role of Gut Microbiome in Cardiovascular Health - Cardiovascular-2025 (France)
- Role of Inflammation in Cardiovascular Diseases - Cardiovascular-2025 (France)
- Safety of drugs and pharmacovigilance - Drug Safety 2024 (France)
- Smart Drug Delivery Systems - Pharmatech 2025 (Canada)
- Smart Polymers for Drug Delivery - Pharmaceutica-2025 (Canada)
- Sustainability and Global Health Biotechnology - Biotech-2025 (France)
- Synthetic and Bioorganic Chemistry - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Targeted Drug Delivery and Controlled Release Systems - PHARMA CONFERENCE-2025 (Czech Republic)
- Targeted Therapies - Personalizedmedicine-2024 (Switzerland)
- Targeted Therapies in Cardiovascular Regeneration - Cardiovascular-2025 (France)
- Targeting the Renin-Angiotensin-Aldosterone System (RAAS) - Cardiovascular-2025 (France)
- Technologies for Formulation - Drug Safety 2024 (France)
- Technology in Pharma Sciences - MedTech-2024 (Switzerland)
- Telemedicine - Personalizedmedicine-2024 (Switzerland)
- The BBB for drug delivery - Drug Safety 2024 (France)
- The Future of Pharma R&D - Future Pharma 2025 (Netherlands)
- The Next Generation Approach of Antibiotics - Antibiotics Resistance 2024 (Canada)
- Therapeutic Drug Transporters - Drug Safety 2024 (France)
- Translational Research - Personalizedmedicine-2024 (Switzerland)
- Translational Research in Pharmacology and Therapeutics - NURSING PHARMACOLOGY 2024 (Netherlands)
- USFDA Approved Biosimilars - Eurobiosimilars 2025 (France)
- Vaccine Delivery Systems - Pharmaceutica-2025 (Canada)
- Vaccine Design and Drug Design - PHARMA CONFERENCE-2025 (Czech Republic)
- Vascular Pharmacology: Focus on Endothelial Dysfunction - Cardiovascular-2025 (France)
- Wearable Drug Delivery Systems - PHARMA CONFERENCE-2025 (Czech Republic)